Elanders AB
Today, Friday March 19, 2021, Elanders is publishing its Annual Report for 2020 on the company website www.elanders.com.
The Annual Report is distributed by mail to those shareholders who have actively ordered a printed version, certain customers and other interested parties.
Elanders AB (publ)
For further information please contact:
Magnus Nilsson, President and CEO, telephone: +46 31 750 07 50
This information is information that Elanders AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 11:00 CET on 19 March 2021.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S6.12.2025 15:30:00 CET | Press release
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Io Therapeutics, Inc.6.12.2025 14:05:00 CET | Press release
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma
Scatec ASA6.12.2025 08:00:00 CET | Press release
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
Junshi Biosciences6.12.2025 04:11:15 CET | Press release
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Zealand Pharma5.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
